Dr. Marcia Sanford Driscoll, MD

Dr. Driscoll practices at University of Maryland Surgical Center in Baltimore, Maryland.

Dr. Driscoll's NPI, 1124127899, was assigned on September 21, 2006. Dr. Driscoll graduated from University of Connecticut School of Medicine in 1993. Dr. Driscoll holds Maryland license D0057983.

Dr. Driscoll's primary practice is University of Maryland Surgical Center, at 419 W Redwood St, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-4080.

Dr. Driscoll's primary practice is University of Maryland Surgical Center in Baltimore, Maryland. Dr. Driscoll is also affiliated with University of Maryland Medical Center. The medical group on file is University of Maryland Dermatology. Dmand AI also links Dr. Driscoll to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Driscoll practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Driscoll's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Driscoll is board certified in dermatology by the American Board of Dermatology. Dr. Driscoll is licensed in Maryland.

CMS data shows 1,692 Medicare services from Dr. Driscoll across 14 procedure codes in 2024, for 460 Medicare patients. Medicare paid $82,213 for them.

CMS counts 460 Medicare patients who saw Dr. Driscoll in 2024. The largest group is 65 to 74, with 213 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Driscoll's median patient age at 47, with 65% women.

In 2024, Dr. Driscoll wrote 537 Medicare Part D claims for 156 patients. 85% of them were for generic drugs. CMS names the drug for 355 of them, across 11 drugs with 11 or more claims each, at $200,205 in total drug cost. In 2023, CMS named 238 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Driscoll for performance year 2024, reported as part of a group. Dr. Driscoll accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 344 procedures of removal of skin lesions by Dr. Driscoll, more than 83% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 27 general payments to Dr. Driscoll from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Novartis Pharmaceuticals Corporation paid the most, $297.

Dr. Driscoll graduated from University of Connecticut School of Medicine in 1993.